Garcia-Gutiérrez, Valentín http://orcid.org/0000-0003-4752-0815
Luna, Alejandro http://orcid.org/0000-0003-2201-3091
Alonso-Dominguez, Juan M.
Estrada, Natalia
Boque, Concepcion
Xicoy, Blanca
Giraldo, Pilar
Angona, Anna
Alvarez-Larrán, Alberto
Sanchez-Guijo, Fermin
Ramírez, María José
Mora, Elvira
Vélez, Patricia
Rosell, Ana
Colorado Araujo, Mercedes
Cuevas, Beatriz
Sagüés, Miguel
Cortes, Montserrat
Encinas, Manuel Perez http://orcid.org/0000-0001-9943-4404
Casado Montero, Luis Felipe
Moreno Vega, Melania
Serrano, Luis
Gomez, Valle
Garcia-Hernandez, Carmen
Lakhwani, Sunil
Paz Coll, Antonio
de Paz, Raquel
Suarez-Varela, Sara
Fernandez-Ruiz, Andrés
Perez Lopez, Raul
Ortiz-Fernández, Almudena
Jiménez-Velasco, Antonio
Steegmann-Olmedillas, Juan Luis
Hernández-Boluda, Juan Carlos
Article History
Received: 9 November 2020
Revised: 13 December 2020
Accepted: 15 January 2021
First Online: 9 February 2021
Conflict of interest
: V.G.G.: Novartis, Incyte, Pfizer and BMS - Speaker Honoraria, advisory committees and research funding; J.M.A.D.: Research funding from Incyte, Celgene, Pfizer, Astellas. BMS - Speaker Honoraria, advisory committees; Pfizer - Speaker Honoraria, advisory committees. Incyte - Advisory committees; J.L.S.: Novartis - Consultancy, Speaker Honoraria, advisory committees; research grants; BMS - Consultancy, Speaker Honoraria, advisory committees; research grants; Pfizer - Consultancy, Speaker Honoraria, advisory committees; research grants: Incyte - Advisory committees. S.L.L.: Novartis - Speaker honoraria, advisory committees; BMS - Speaker honoraria. The rest of the authors declare that they have no conflict of interest.